1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Therapy

What Are the Most Profitable Therapies? Market Trends & Strategies Explained

  • Currently 2/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
16 votes

Global Therapy Industry 

The global therapy industry (one large revenue center of the pharma industry) involves treatments intended to protect from, cure or manage specific illnesses. The treatment of each therapeutic area and its specific conditions varies widely.

Therapy is usually decided on once the patient has been diagnosed with a specific medical condition or disease, though therapies may also be preventive measures. Therapies applied following diagnosis are either abortive or supportive. The former is a curative measure that seeks to inhibit development of the condition, while the latter relieves the patient’s suffering due to the symptoms of the disease without treating the condition itself.

Preventive therapies are used to safeguard people against disease; for example, vaccinations are used to prevent infections such as polio, smallpox and measles.

Market Trends

The combined market for medicines and therapies (such as oncology) used in the treatment of disease is witnessing a slower rate of spending: in the five years up to 2010, spending on medicines grew by more than 6% yearly. However, in the five years up to 2015, the rate of growth is slowing to between 3% and 6%. Global spending on medicine and therapy in 2015 is forecast to reach $1.1 trillion, reports the IMS Institute for Healthcare and Informatics.

The market is to see increased spending on generic drugs, hitting almost 40% growth in 2015 or nearly doubling in a decade. Spending on brand-name medicines should drop by $120 billion in the five-year period ending in 2015.

Increased prevalence of type 2 diabetes, particularly in emerging markets such as China, Brazil and India, will see global spending on the disease rise 4%-7% through 2015, with oral antidiabetics increasingly favored. Spending on therapeutic medicine to treat asthma and chronic obstructive lung disease will drop from 9% in the five-year period ending in 2010 to 2%-5% from 2010 to 2015.

Therapy Spending Forecasts to 2015 *In US$ Billion 

Key Market Segments

According to a report by the IMS Institute for Healthcare Informatics, oncology will continue to hold the top spot in the therapies industry, with forecast revenue between $75 billion and $80 billion in 2015, representing a jump of more than $20 billion in a five-year period. Lipid regulators will fall from second to fourth place, reaching between $29 billion and $34 billion in the same period. Meanwhile, anti-diabetics will rise to second place at between $43 billion and $48 billion.

Respiratory agents are expected to remain the third-biggest seller, with a $5 billion to $10 billion increase on 2010 sales. Drugs to treat hypertension are forecast to rise to fifth place with an up to $6.5 billion increase in revenue. Overall, auto-immune drugs should see a substantial jump to reach between $27 billion and $32 billion by 2015.

HIV antivirals are expected to jump from tenth to seventh place with sales of between $20 billion and $24 billion by 2015. A substantial drop in market share is expected for antidepressants, from more than $20 billion in 2010 to between $13 billion and $16 billion in 2015.  Treatments for multiple sclerosis should rise several places in the same period, marking revenue from under $10 billion to between $12 billion and $15 billion. Antipsychotics are forecast to see a $5 billion drop to $20 billion in 2015.

Therapy segments expected to drop out of the top-20 list include vitamins and minerals, antirheumatics, cephalosporins, combs (antibiotics) and vaccines. Categories expected to appear in the top 20 include treatments for glaucoma, Alzheimer’s, osteoporosis and attention deficit hyperactivity disorder.

Categories expected to show less substantial fluctuation include narcotic analgesics, antiepileptics and erythropoietics.

Top 20 Global Therapeutic Categories (2015) 

Read more »

You might be interested in these related markets:

Customer Support

Talk to Sam

+44 208 068 8943

1600 Reports
Supply, Demand, Company
5200 Statistics
Market Size, Demand, Company
10000 Reports
Company Financials, Company, Demand
16000 Statistics
Market Size, Finance, Company Financials
520 Reports
Demand, Company Financials, Company
1900 Statistics
Market Size, Demand, Finance
380 Reports
Demand, Company Financials, Supply
1900 Statistics
Market Size, Demand, Finance
1400 Reports
Demographic, Social Conditions, Supply
4700 Statistics
Demographic, Environment, Market Size
400 Reports
Supply, Company Financials, Demand
3100 Statistics
Market Size, Demand, Finance
680 Reports
Supply, Demographic, Demand
1400 Statistics
Demographic, Environment, Social Conditions
740 Reports
Company, Demographic, Supply
1200 Statistics
Market Size, Environment, Demand
63 Reports
Demand, Supply, Company Financials
570 Statistics
Market Size, Demand, Demographic
130 Reports
Demand, Company Financials, Supply
620 Statistics
Market Size, Demand, Finance
Search in Therapy Industry (About 33000 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Drug Discovery and Development, Generic Drug, OTC, Prescription Drug

About 13000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 165 - $ 75000)

2018 World Clinical Chemistry Analyzers and Reagents Market: Emerging Opportunities in the Americas, EMEA, APAC--A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

2018 World Clinical Chemistry Analyzers and Reagents Market: Emerging Opportunities in the Americas, EMEA, APAC--A 74-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 75000
  • Industry report
  • March 2018
  • by Venture Planning Group

This new 74-country report from VPGMarketResearch.com is available by region, country, market segment, section, or individual test.The report provides a granular strategic analysis of over 100 clinical ...

Immunodiagnostics Analyzers and Reagents Market 2021: A ... $ 75000 July 2017

Clinical Chemistry Reagents and Analyzers Market 2021: ... $ 75000 May 2017

2018 World Cancer Diagnostics Market: Emerging Opportun ... $ 52400 March 2018

Tumor Markers Testing Market 2021: A 74-Country Analysi ... $ 52400 June 2017

Cancer Diagnostics Market 2021: A 74-Country Analysis-- ... $ 52400 May 2017

2018 Europe Clinical Chemistry Analyzers and Reagents M ... $ 37500 March 2018

Europe Immunodiagnostics Analyzers and Reagents Market ... $ 37500 July 2017

Europe Clinical Chemistry Reagents and Analyzers Market ... $ 37500 May 2017

2018 Europe Cancer Diagnostics Market: A 31-Country Ana ... $ 36000 March 2018


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on